Pages that link to "Q30462825"

The following pages link to Pharmacological enhancement of fear reduction: preclinical models (Q30462825):

Displaying 27 items.

• Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders (Q27006437) (← links)
• Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders (Q28396555) (← links)
• Sex differences in animal models of psychiatric disorders (Q30401732) (← links)
• Can fear extinction be enhanced? A review of pharmacological and behavioral findings (Q30410131) (← links)
• The age of anxiety: role of animal models of anxiolytic action in drug discovery (Q30462832) (← links)
• The endocannabinoid system in anxiety, fear memory and habituation (Q30471032) (← links)
• The study of fear extinction: implications for anxiety disorders (Q33988524) (← links)
• HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand? (Q34410902) (← links)
• A novel UCS memory retrieval-extinction procedure to inhibit relapse to drug seeking (Q35877732) (← links)
• Reconsolidation of a cocaine associated memory requires DNA methyltransferase activity in the basolateral amygdala (Q35974478) (← links)
• Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model (Q36328780) (← links)
• Individual differences in the expression of conditioned fear are associated with endogenous fibroblast growth factor 2. (Q36569103) (← links)
• A high-throughput clinical assay for testing drug facilitation of exposure therapy (Q36977590) (← links)
• Temporal factors in the extinction of fear in inbred mouse strains differing in extinction efficacy. (Q37053613) (← links)
• Fear extinction causes target-specific remodeling of perisomatic inhibitory synapses (Q37341518) (← links)
• Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice. (Q37491564) (← links)
• Reconsolidation of drug memories (Q37985308) (← links)
• Novel pharmacological agents targeting memory and cognition in the treatment of anxiety disorders (Q38137924) (← links)
• Threat processing: models and mechanisms. (Q38565424) (← links)
• Extinction after fear memory reactivation fails to eliminate renewal in rats. (Q38919850) (← links)
• Periaqueductal gray c-Fos expression varies relative to the method of conditioned taste aversion extinction employed (Q38925087) (← links)
• Ethical concepts and future challenges of neuroimaging: an Islamic perspective (Q39574125) (← links)
• Potentiating mGluR5 function with a positive allosteric modulator enhances adaptive learning (Q43082537) (← links)
• The endocannabinoid system in guarding against fear, anxiety and stress (Q47618301) (← links)
• Facilitation of fear extinction by the 5-HT(1A) receptor agonist tandospirone: possible involvement of dopaminergic modulation (Q48295554) (← links)
• Intraamygdala infusion of fibroblast growth factor 2 enhances extinction and reduces renewal and reinstatement in adult rats (Q48859271) (← links)
• Rodent models of impaired fear extinction (Q58091557) (← links)